郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Anxiogenic and Stressor Effects of the Hypothalamic Neuropeptide RFRP-3 Are Overcome by the NPFFR Antagonist GJ14.

期刊：Endocrinology发表年份：2015作者：Joon S Kim; Phil W Brownjohn; Blake S Dyer; Massimiliano Beltramo; Christopher S Walker; Debbie L Hay; Gavin F Painter; Joel D A Tyndall; Greg M Anderson
阅读更多 →

药效评价Rutaecarpine and evodiamine selected as β1-AR inhibitor candidates using β1-AR/CMC-offline-UPLC/MS prevent cardiac ischemia-reperfusion injury via energy modulation.

期刊：Journal of pharmaceutical and biomedical analysis发表年份：2015作者：Hui Xue; Yongjie Cheng; Xin Wang; Yuan Yue; Weifang Zhang; Xiaoni Li
阅读更多 →

药效评价Screening β1AR inhibitors by cell membrane chromatography and offline UPLC/MS method for protecting myocardial ischemia.

期刊：Journal of pharmaceutical and biomedical analysis发表年份：2015作者：Yuan Yue; Lili Dou; Xin Wang; Hui Xue; Yanhong Song; Xiaoni Li
阅读更多 →

药效评价Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.

期刊：Bioorganic & medicinal chemistry发表年份：2015作者：Chaela S Presley; Suni M Mustafa; Ammaar H Abidi; Bob M Moore
阅读更多 →